🇺🇸 FDA

Company profile · Sponsor

INTENSITY

INTENSITY THERAPEUTICS, INC.

INTS · NYSE biotech SHELTON, CT, USA
Pipeline
6
Drugs
0
Patents
3

Quick answer

INTENSITY (INTS) is a biotech company. headquartered in SHELTON, CT, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 3 patents to this profile..

Company facts

Ticker INTS
Exchange NYSE
Company type biotech
Headquarters SHELTON, CT, USA
SEC CIK 0001567264

Pipeline (6)

Search pipeline →

  1. INT230-6

    INTENSITY

    Sarcoma,Soft Tissue

    phase 3 small molecule active

    1 trial

  2. Trabectedin EVER Pharma 1 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, Pazopanib PharOS 200 mg film-coated tablets, HALAVEN 0.44 mg/ml solution for injection

    INTENSITY

    liposarcoma (dedifferentiated, myxoid, round cell or pleomorphic), Leiomyosarcoma (non-uterine), Undifferentiated pleomorphic sarcoma

    phase 3 small molecule active

    1 trial

  3. INT230-6

    INTENSITY

    Breast Cancer

    phase 2 small molecule active

    2 trials

  4. JIN-A02

    INTENSITY

    EGFR Mutant Advanced Non-small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  5. MPT0B640

    INTENSITY

    Advanced Solid Tumor

    phase 1 small molecule terminated

    1 trial

  6. MPT0B640

    INTENSITY

    Covid19

    phase 1 small molecule terminated

    1 trial

Patents (3)

Search patents →

  1. US 10888618

    Method of treating cancer

    Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9636406

    Method of treating cancer

    Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9351997

    Method of treating cancer

    Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is INTENSITY?

INTENSITY (INTS) is a biotech company. headquartered in SHELTON, CT, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 3 patents to this profile..

What pipeline programs does INTENSITY sponsor?

We track 6 ClinicalTrials.gov-linked programs for INTENSITY, including INT230-6 and 5 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does INTENSITY company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.